7.5. Analysis.
Comparison 7: Platinum‐sensitive recurrent EOC: PARPi with chemotherapy and as maintenance therapy compared with chemotherapy alone, Outcome 5: Any severe adverse event (grade 3 or higher)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.